-
Proposed Fiscal Anchor Threatens South Africa’s Constitutional Rights Amid Health Crisis
-
BYD Dolphin G Leasing Deal: Plug-in Hybrid Supermini Available from £174 a Month
-
JUEL Group Expands from Real Estate to Hospitality with Hyatt Centric Malta Opening
-
Three Inaugural CombatX Champions Crowned at BRAVE CF Road to BRAVE Event in Hungary
-
French Economy Shrinks 0.1% as Consumer Confidence Slumps
-
China's Factory Activity Contracts as Export Orders Weaken
-
Wall Street Ends Turbulent Week Higher Despite Inflation and AI Jitters
-
US Retail Sales and Fed Minutes Set Up a Critical Test for Consumers
-
Kansas City Fed Chief Says Inflation Is Still Running Too Hot
-
Oil Heads for Second Weekly Loss as Supply Surplus Emerges
-
Asian Markets Slide as AI Concerns Hit Chip Stocks
-
Four Mainland Universities Join Scheme for Hong Kong DSE Admissions from 2027
-
Brazil Faces Debt and Inflation Test as Lula Prepares Fourth Term
-
Canada Signals Openness to Chinese Automakers if US Trade Talks Fail
-
Chinese Drug Ribupatide Shows Greater Weight Loss Than Wegovy in Clinical Trial
-
Canada Expands Asian Trade Push as US Negotiations Resume
-
US Mortgage Rate Falls for Fourth Week but Remains Above 7%
-
US Jobless Claims Rise to 200,000 but Layoffs Remain Historically Low
-
Italy Raises 2026 Growth View but Warns Energy Will Keep Inflation High
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
Thomas Tuchel Refuses to Name England Number One Goalkeeper After James Trafford's Display
-
Helen Haines Discharged from Hospital Following Attack That Cost Her Both Legs
Global diabetes rate has doubled in last 30 years: study
The percentage of adults suffering from diabetes across the world has doubled over the past three decades, the biggest rises coming in developing countries, a study said Wednesday.
The serious health condition affected around 14 percent of all adults worldwide in 2022, compared to seven percent in 1990, according to the new analysis in The Lancet journal.
Taking into account the growing global population, the team of researchers estimated that more than 800 million people are now diabetic, compared to less than 200 million in 1990.
These figures include both main types of diabetes. Type 1 affects patients from a young age and is more difficult to treat because it is caused by an insulin deficiency.
Type 2 mainly affects middle-aged or older people who lose their sensitivity to insulin.
Behind the global numbers, national figures varied widely.
The rate of diabetes stayed the same or even fell in some wealthier countries, such as Japan, Canada or Western European nations such as France and Denmark, the study said.
"The burden of diabetes and untreated diabetes is increasingly borne by low-income and middle-income countries," it added.
For example, nearly a third of women in Pakistan are now diabetic, compared to less than a tenth in 1990.
The researchers emphasised that obesity is an "important driver" of type 2 diabetes -- as is an unhealthy diet.
The gap between how diabetes is treated in richer and poorer countries is also widening.
Three out of five people aged over 30 with diabetes -- 445 million adults -- did not receive treatment for diabetes in 2022, the researchers estimated.
India alone was home to almost a third of that number.
In sub-Saharan Africa, only five to 10 percent of adults with diabetes received treatment in 2022.
Some developing countries such as Mexico are doing well in treating their population -- but overall the global gap is widening, they said.
"This is especially concerning as people with diabetes tend to be younger in low-income countries and, in the absence of effective treatment, are at risk of life-long complications," said senior study author Majid Ezzati of Imperial College London.
Those complications include "amputation, heart disease, kidney damage or vision loss -- or in some cases, premature death," he said in a statement.
J.Horn--BTB